Archit Organosys Ltd Valuation
ARCHITORG · Chemicals · Current price ₹62.5
Is Archit Organosys Ltd undervalued?
DocStoX estimates the fair value of Archit Organosys Ltd at ₹25 per share, versus the current market price of ₹63. That puts the stock about -60.0% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹33), Relative P/E (₹16), Graham floor (₹17). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹16 (bear) to ₹25 (base) to ₹33 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Archit Organosys Ltd trades at a P/E of 25.4x and a P/B of 1.7x, with a dividend yield of 0.8%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Archit Organosys Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.